XML 49 R40.htm IDEA: XBRL DOCUMENT v3.23.4
Business Segment (Details) - Schedule of Operations by Business Segment - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Segment Reporting Information [Line Items]        
Revenue $ 10 $ 14 $ 35 $ 93
Earnings (3,660) (41,026) (22,592) (76,932)
FOXO Labs [Member]        
Segment Reporting Information [Line Items]        
Revenue 6 7 20 71
Earnings (269) (500) (873) (1,952)
FOXO Life [Member]        
Segment Reporting Information [Line Items]        
Revenue 4 7 15 22
Earnings (139) (1,158) (1,029) (3,070)
FOXO Technologies Inc [Member]        
Segment Reporting Information [Line Items]        
Revenue 10 14 35 93
Earnings (408) (1,658) (1,902) (5,022)
Impairment [Member]        
Segment Reporting Information [Line Items]        
Earnings [1] (2,633)
Stock Issuances [Member]        
Segment Reporting Information [Line Items]        
Earnings [2] (3,521)
Corporate and Other [Member]        
Segment Reporting Information [Line Items]        
Earnings [3] (3,104) (38,944) (13,671) (70,660)
Interest Expense [Member]        
Segment Reporting Information [Line Items]        
Earnings $ (148) $ (424) $ (865) $ (1,250)
[1] See Note 4 for additional information on the digital insurance platform, underwriting API, and longevity API impairment.
[2] Stock issuances includes the 2022 Bridge Debenture Release and the PIK Note Amendment. See Notes 5 and 7 for additional information.
[3] Corporate and other includes equity-based compensation, including the consulting agreement and Cantor Commitment Fee, expense of ($1,312) and $3,866 as well as depreciation and amortization expense of $5 and $74 for the three months ended September 30, 2023 and 2022, respectively. Corporate and other includes equity-based compensation, including the consulting agreement and Cantor Commitment Fee, expense of $2,582 and $5,556 as well as depreciation and amortization expense of $1,251 and $159 for the nine months ended September 30, 2023 and 2022, respectively. The three months ended September 30, 2023 and 2022 included ($36) and $31,010 for the changes in fair value of convertible debentures, warrant liability, and forward purchase derivatives. The nine months ended September 30, 2023 and 2022 also included ($244) and $55,493 for the changes in fair value of convertible debentures, warrant liability, and forward purchase derivatives. See Notes 4, 6, and 9 for additional information.